Spangler Leslie, Ichikawa Laura E, Hubbard Rebecca A, Operskalski Belinda, LaCroix Andrea Z, Ott Susan M, Scholes Delia
Center for Observational Research, Amgen Inc., Thousand Oaks, CA.
Group Health Research Institute, Group Health Cooperative, Seattle, WA.
Ann Epidemiol. 2015 Jan;25(1):55-9. doi: 10.1016/j.annepidem.2014.10.009. Epub 2014 Oct 16.
Oral contraceptive (OC) use can occur throughout a woman's reproductive life span with the potential for long-term impacts on health. To assess potential measurement error in prior OC use, this study compared level of agreement between self-reported prior OC use and pharmacy dispensing data in perimenopausal and/or early postmenopausal women.
The study's 1399 women (ages, 45-59 years) were participants in a population-based case-control study of the association between OC use and fracture risk. Episodes of lifetime self-reported OC use (in months) were collected, by telephone interview, for January 1, 2008 through November 25, 2012. Pharmacy fills, back to 1980, were collected from automated data. Agreement was measured using the prevalence-adjusted and bias-adjusted kappa index.
The number of women with OC pharmacy fills was 11% to 45% higher than those who reported OC use during each time period. Between-measures agreement was better for more recent use. Prevalence-adjusted and bias-adjusted kappa index values ranged from 0.88 (95% confidence interval, 0.85-0.90) within 5 years from the reference date to 0.65 (95% confidence interval, 0.59-0.71) within 15 to 20 years.
For studies designed to assess the long-term effects of OC use, the current results are reassuring in noting moderate agreement between self-reported OC use and pharmacy data for up to 15 to 20 years before the interview.
口服避孕药(OC)的使用贯穿女性的整个生殖寿命期,可能对健康产生长期影响。为评估既往OC使用情况潜在的测量误差,本研究比较了围绝经期和/或绝经后早期女性自我报告的既往OC使用情况与药房配药数据之间的一致性水平。
该研究中的1399名女性(年龄45 - 59岁)参与了一项基于人群的病例对照研究,该研究旨在探讨OC使用与骨折风险之间的关联。通过电话访谈收集了2008年1月1日至2012年11月25日期间自我报告的终身OC使用时长(以月为单位)。从自动化数据中收集了可追溯至1980年的药房配药记录。使用患病率调整和偏差调整的kappa指数来衡量一致性。
在每个时间段内,有OC药房配药记录的女性人数比报告使用OC的女性人数高11%至45%。对于更近时期的使用,不同测量方法之间的一致性更好。患病率调整和偏差调整的kappa指数值范围从参考日期起5年内的0.88(95%置信区间,0.85 - 0.90)到15至20年内的0.65(95%置信区间,0.59 - 0.71)。
对于旨在评估OC使用长期影响的研究,当前结果令人安心,因为在访谈前长达15至20年的时间里,自我报告的OC使用情况与药房数据之间存在适度的一致性。